2017 Vancouver Congress Disclosures Relationship Full Name Role(s) Relationship Type No relevant financial interests to disclose for this Geraldine Acuna-Sunshine Speaker course.

Charles H. Adler, MD, PhD Chair, Planner Adamas, Cynapsus, Jazz, Lundbeck, Merz. Consultant Federica Agosta Speaker EXCEMED Excellence in Medical Education Honoraria Consultant Alberto Albanese, MD Speaker Ipsen, Merz, Medtronic, Boston Scientific Honoraria

Living Cell Technologies Ltd Consultant

New Zealand Brain Research Ltd Clinical Network Services (CNS)Pty Ltd Tim J. Anderson, FRACP, MD Chair, Planner PharmaNet Pty Ltd Novotech New Zealand Ltd Grant/Research inVentive Health Clinical Support Boehringer-Ingelheim (Thai) Ltd Allergan Honoraria UCB, AbbVie, Acadia, Boehringer Ingelheim, Angelini Pharmaceuticals Consultant Angelo Antonini, MD, PhD Speaker UCB, AbbVie, Zambon, GE, Medscape, PeerVoice Honoraria An in vitro method of diagnosing Parkinson's disease Patent N: WO 2015110261 A1 Royalty

Merz, Allergan Consultant Grant/Research Silke Appel-Cresswell, MD Chair Replicel Support (Spouse) Merz Honoraria

Alberto Ascherio, MD, DrPH Chair, Planner No relevant financial interests to disclose

Medtronic Europe Grant/Research Peter G. Bain, MA, MD, FRCP Chair, Speaker InsighTec 2016 MRgFUS trial for essential Support tremor.

No relevant financial interests to disclose for this Bettina C.A. Balint, MD Speaker course.

Rudi Balling Speaker Bayer Consultant UCB, Zambon, Lundbeck Paolo Barone, MD, PhD Chair Consultant Zambon, UCB Honoraria

Hilla Ben-Pazi, MD Speaker Ipsen Grant/Research Support No relevant financial interests to disclose for this Fabrizio Benedetti Speaker course No relevant financial interests to disclose for this Brian D. Berman, MD, MS Speaker course Grant/Research Alfredo Berardelli, MD Reviewer Allergan, Ipsen, Lundbeck, UCB, Chiesi Support

Erwan Bezard, PhD Speaker Motac Holding Consultant, Ownership

Ipsen, Allergan, Merz Consultant Chair, Speaker, Kailash P. Bhatia, MD, DM, FRCP Reviewer Ipsen, UCB, Allergan, Merz, GSK, , Sun Pharma, Teva Honoraria Kalyan B. Bhattacharyya, MD, DM, No relevant financial interests to disclose for this Speaker MAMS, FRCP course.

Thomas D. Bird, MD Chair, Speaker No relevant financial interests to disclose

Bastiaan R. Bloem, MD, PhD Chair No relevant financial interests to disclose

GE Healthcare; FORUM Pharmaceuticals; C2N Bradley F. Boeve, MD Speaker Grant/Research Diagnostics; Axovant Support LSP Life Sciences Fund Consultant Springer Science + Business Media, LCC, and Sun Pharmaceutical Laboratories Limited Honoraria Chair, Vincenzo Bonifati, MD, PhD Planner,Speaker Co-inventor in a patent application concerning the SYNJ1 gene. Royalty Co-inventor in a patent application related to deep brain stimutation. Royalty (Spouse)

F. Hoffmann - La Roche Ltd. (consultancies) Per Borghammer, MD, PhD, DMSc Speaker Consultant Asceneuron, Ionis, Janssen, Merck, Alector, Delos Consultant Adam Boxer, MD, PhD Chair, Speaker Archer, Avid, , C2N, Bristol Myers Grant/Research Squibb, , Eli Lilly, Forum,TauRx Support Patent for DYT6 kit through Icahn School of Susan B. Bressman, MD Speaker Medicine Royalty Patents on identification of new genes and targets for neurological disorders Alexis Brice, MD Chair, Speaker Royalty

Patents on new targets for neurological diseases Royalty (Spouse)

No relevant financial interests to disclose for this Gila Bronner, MPH, MSW, CST Speaker course No relevant financial interests to disclose for this Adolfo M. Bronstein, MD Speaker course

Medtronic Peter Brown, MD, FRCP Speaker Consultant Boston Scientific Honoraria

Profile Pharma David John Burn, MD, FRCP Chair Honoraria Paolo Calabresi, MD Speaker UCB Pharma and Zambon. Honoraria

Nicole Calakos, MD, PhD Speaker Use of genetically modified reporter mouse line Royalty No relevant financial interests to disclose for this Colleen G. Canning, PhD Speaker course

Teva, Zambon Francisco Cardoso, MD, PhD, FAAN Chair Consultant Teva, UCB Honoraria No relevant financial interests to disclose for this Manolo Carta Speaker course UCB Pharma, General Electric, Boehringer Roberto Ceravolo, MD Speaker Ingelheim, GSK, Novartis, Lundbeck, Zambon, , Chiesi, Eli Lilly, FB Health, Abbvie Honoraria Britannia, AbbVie, Mundipharma, UCB, Global Kinetics corporation, Cynapsus Consultant Britannia Pharmaceuticals, AbbVie, UCB Grant/Research Support K. Ray Chaudhuri, MD, FRCP, DSc Chair, Planner Britannia, AbbVie, Mundipharma, UCB, Global Kinetics corporation, Cynapsus Britannia UCB Mundipharma Honoraria Grant/Research Medtronic, Merz Support Robert Chen, MBBChir, MSc, FRCPC Speaker Allergan, Merz, UCB Honoraria DartNeuro (2016) Consultant

Gladstone Institute UCSC Orphagen Pharmaceuticals Io Therapeutics Marie-Francoise Chesselet, MD, PhD Chair, Planner ADM Diagnostics Paganini Therapeutics IDbyDNA Consultant (Spouse) Tsumura Pharmaceuticals, Neurophage Inc. Isis Pharmaceuticals, CA, Genentech,CA, Neuropore, CA, Amicus Pharmaceuticals Grant/Research Support

Sun Ju Chung, MD, PhD Speaker AbbVie and Dong-A Consultant

Ipsen, Merz, Zambon Consultant Carlo Colosimo, MD, FEAN Chair, Planner Ipsen Grant/Research Support No relevant financial interests to disclose for this Mark R. Cookson, PhD Speaker course No relevant financial interests to disclose for this Daniel Montie Corcos, PhD Chair, Speaker course Pfizer, Zambon, BMS Consultant Jean-Christophe Corvol, MD, PhD Speaker Ipsen Grant/Research Support Carlos Cosentino, MD Chair, Speaker Teva and Boehringer Ingelheim Honoraria

Nabila A. Dahodwala Reviewer Biotie Grant/Research Support

Abbvie, Civitas Therapeutics, Teva Consultant Grant/Research Abbvie; Civitas Therapeutics, Teva Esther Cubo Delgado, MD, PhD Speaker Support

Abbvie Honoraria

NWO Medium, Fonds Nuts-Ohra, Prinses Beatrix Fonds , Stichting wetenschapsfonds dystonie vereniging, Fonds Psychische Marina AJ De Koning-Tijssen, MD, Chair, Planner gezondheid, Phelps Stichting, Beatrix PhD kinderziekenhuis fonds. Unrestricted grants from Actelion, Merz, Ipsen, Allergan Farmaceutics & Grant/Research Medtronic. Support

Bettina H. Debu, PhD Chair, Speaker No relevant financial interests to disclose

Boston Scientific Consultant Günther Deuschl, MD Chair, Speaker

Medtronic, Desitin, Allmiral Honoraria No relevant financial interests to disclose for this Aloysius Domingo, MD Speaker course

Doris J. Doudet, PhD Chair No relevant financial interests to disclose No relevant financial interests to disclose for this Kathy Dujardin, PhD Speaker course COEN WIN HD Alexandra Durr, MD, PhD Speaker ANAPURNA Grant/Research VERUM Support No relevant financial interests to disclose for this Petr Dusek, MD Speaker course

No relevant financial interests to disclose for this Darius Ebrahimi-Fakhari, MD, PhD Speaker course

Mark J. Edwards, MBBS, BSc, Reviewer UCB Pharma Royalty FRCP, PhD

David Eidelberg, MD Chair, Speaker No relevant financial interests to disclose

Yvonne Eisele, PhD Chair, Speaker No relevant financial interests to disclose

No relevant financial interests to disclose for this Simone Engelender, MD, PhD Speaker course No relevant financial interests to disclose for this Roberto Erro, MD Speaker course Mertz Giovanni Fabbrini, MD Speaker Allergan Grant/Research Zambon Support Adamas Pharmaceuticals; Lifemax Laboratories; Stanley Fahn, MD Speaker Cynapsus therapeutics Consultant Ionis Pharmaceuticals Grant/Research Support

US patent W0 2005/004794 A2 & JP 2011- 30292 for a method of treating neurodegenerative diseases; identification of a novel LRRK2 mutation, 6055G>A (G2019S), linked to autosomal dominant parkinsonism in families from several European populations. [(a) International Publication Number WO 2006/045392 A2; (b) International Publication Matthew J. Farrer, PhD Speaker Number WO 2006/068492 A1; (c) US publication Number US-2008-0009454-A1; and (d) Norwegian patent 323175]. Intellectual Property Rights The patents listed above are licensed to , Athena Diagnostics and H.Lundbeck A/S. Merck, H. Lundbeck A/S and Ionis Royalty Pharmaceuticals also licence the use of related mouse models through Mayo Foundation (models created whilst a Mayo employee).

Biogen, GE Health Care, Lundbeck, Merz Consultant Pharmaceuticals and Pfizer Pharmaceuticals, Hubert H. Fernandez, MD Speaker Biogen, GE Health Care, Lundbeck, Merz Pharmaceuticals and Pfizer Pharmaceuticals, as Honoraria a consultant.

GlaxoSmithKline, TEVA, Novartis, Lundbeck, Abbott, Bial, Merck-Serono, Merz, Ipsen, Consultant Biogen, Solvay, Sunovision Pharmaceuticals Joaquim J. Ferreira, MD, PhD Chair Fundacao MSD (Portugal), Teva, MSD, Allergan, Ipsen, Novartis, Grant/Research Medtronic,GlaxoSmithKline, Grunenthal Support

Royalties related to patents for HSP Gene John K. Fink, MD Speaker Royalty testing (SPG3A, SPG6)

Steven Finkbeiner, MD, PhD Chair, Speaker iPierian, LINK, Proteastasis, Vertex

Consultant

Medtronic, Neuropace, Consultant Kelly D. Foote, MD Chair,Planner Medtronic, St. Jude, Neuropace, Boston Grant/Research Scientific, Functional Neuromodulation Support

Susan H. Fox, MRCP (UK), PhD Speaker Adamas, Acadia, Avanir, Lundbeck, Prexton Consultant

Jennifer R.L. Friedman, MD Speaker Stealth Biotherapeutics - Clinical Trial Grant/Research Support Jennifer R.L. Friedman, MD Speaker Stealth Biotherapeutics - Clinical Trial Grant/Research Support No relevant financial interests to disclose for this Fumino Fujiyama, MD, PhD Chair, Speaker course

Abbvie, Allergan, Boehringer-Ingelheim, Ipsen, Merz, Mundi Pharma, Stada, Teva and UCB Victor Fung, MBBS, PhD, FRACP Chair, Speaker Consultant Grant/Research Abbvie Support

Ziv Gar-Or Speaker /Genzyme Honoraria/Speaker's Bureau

Tuteur SA; Bago Argentina; UCB, Glaxo Smith Klein, Allergan, Boehringer Ingelheim; Genzyme a Sanofi company; Teva; Buxton Consultant Glaxo Smith Klein Novartis Argentina Emilia Mabel Gatto, MD Speaker UCB educational program expert latam Bago educational program Tuteur educational program Allergan educational program Boehringer Ingelheim educational program, Genzyme a Sanofi Company educational program; Honoraria

Oscar S. Gershanik, MD Chair,Planner No relevant financial interests to disclose

Teva-Lundbeck, Intec Pharma, Neuroderm, Armon Neuromedical Ltd.\ Dexel, Pharma Two B, LTI, Ponffort Consultant Nir Giladi, MD Chair, Speaker Grant/Research Teva Innovative Ltd. NNE Support

Teva-Lundbeck, Novartis, UCB, Genzyme, Sheir Honoraria Acadia, Addex, Avanir, Boston Scientific, Christopher G. Goetz, MD Chair, Planner Clevexel, Oxford Biomedica, Pfizer. Consultant Acadia, Biogen, Pfizer, Teva Consultant Jennifer G. Goldman, MD, MS Speaker Pri-Med, MedEdicus Honoraria

Teva, Pfizer, Abvie Grants/Research

Mark Guttman, MD, FRCPC Speaker Novartis Honoraria

Neuroderm Stock Ownership

Deborah A. Hall, MD PhD Speaker Neurocrine, Pfizer Grant/Research Support No relevant financial interests to disclose for this Penelope J. Hallett, PhD Speaker course

Glenda M. Halliday, PhD Chair, Speaker No relevant financial interests to disclose Glenda M. Halliday, PhD Chair, Speaker No relevant financial interests to disclose

Hisamitsu Pharmaceutical Co.,Inc Otsuka Pharmaceutical, Kyowa Hakko Kirin, Meiji Seika Pharma, Consultant

Otsuka Pharmaceutical, Boehringer Ingelheim, Kyowa Hakko-Kirin Pharmaceutical Company, Nihon Medi-Physics, Medtronic, Inc., Eisai, and FP Pharmaceutical Corporation, Takeda Grant/Research Pharmaceutical Company, Boston scientific Nobutaka Hattori, MD, PhD Chair, Speaker Support Nippon Boehringer Ingelheim,Co.,Ltd, FP Pharmaceutical Corporation, Otsuka Pharmaceutical, Co.,Ltd., Dai-Nippon Sumitomo Pharma Co.,Ltd., Novartis Pharma K.K, Eisai Co.,Ltd., Medtronic, Inc., Kissei Pharmaceutical Company, Nihon Medi-physics Co.,Ltd., Daiichi- Sankyo, Takeda Pharmaceutical Company, and Kyowa Hakko-Kirin Co.,Ltd.. Honoraria

Jeffrey M. Hausdorff, PhD Speaker TEVA Employee (Spouse) Grant/Research Susan J. Hayflick, MD Speaker Clene nanomedicine Support

Dan G. Healy, MD Speaker Abbott, Teva, Boheringer, UCB, Honoraria NeuroDerm, GKC Consultant Grant/Research Tove Henriksen, MD Speaker Toledo Study by Britannia Support AbbVie, UCB, Teva, Zambon, Nordic Infucare, Grünenthal Honoraria No relevant financial interests to disclose for this Elke Heremans, PhD Speaker course. Supported in part by Grants-in-Aid for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS9) and Research and Development Grants for Dementia from the Makoto Higuchi Speaker Japan Agency for Medical Research and Grant/Research Development. Support The speaker is named as inventor on a patent claiming subject matter related to tau imaging Intellectual Property agents. Rights

AbbVie, Alzprotect, Asceneuron, Bristol-Myers Consultant Squibb, Roche, Sellas Life Sciences Group, UCB Günter U. Höglinger, MD Chair, Planner Abbvie, Roche, Teva, UCB Honoraria

MedImmune Consultant Sarosh R. Irani, MD PhD Chair, Speaker Grant/Research IUCB Pharma Support

Lundbeck, Peptron Consultant Beomseok (BJ) Jeon, MD, PhD Chair Novartis, Ipsen, UCB, Sandoz, Samil Grant/Research Support Chair, Planner, Medtronics, Inc., Retrophin, Inc. Hyder A. Jinnah, MD, PhD Consultant Speaker Saol Therapeutics, Inc. GlaxoSmithKline, Prestwick, Teva, Allergan, Boehringer Ingelheim, Merz, Abbvie, Boston Consultant Scientific, Ipsen Mandar Shrikrishna Jog, MD Speaker GlaxoSmithKline, Teva, Allergan, CIHR, Ontario Brain Institute, Merz, MITACS, Abbvie, Boston Grant/Research Scientific, OCE Support Petr Kanovsky, MD, PhD Chair, Speaker Merz, Ipsen, Allergan, Medtronic Honoraria No relevant financial interests to disclose for this Toshitaka Kawarai, MD Speaker course No relevant financial interests to disclose for this Han-Joon Kim, MD Speaker course

Abbvie, Global Kinetics Corporation Consultant Thomas E. Kimber, MD, PhD Speaker Abbvie, Global Kinetics Corporation, Grant/Research Medtronic Support Abbvie Honoraria

Christine Klein, MD Chair, Planner Centogene, Biogen Consultant

No relevant financial interests to disclose for this Benzi M. Kluger, MD Speaker course No relevant financial interests to disclose for this Shunsuke Kobayashi Speaker course

Cynapsus Therapeutics Consultant, Honoraria Aikaterini Kompoliti, MD Chair, Speaker Grant/Research Lundbeck, Neurocrine Support

Jeffrey H. Kordower, PhD Chair, Speaker Brainstom - stock Ownership

Lysosomal Therapeutics Dimitri Krainc, MD, PhD Chair, Speaker Consultant Intellia Therapeutics

Medtronic Consultant

Deutsche Forschungsgemeinschaft (DFG) Grant/Research Joachim K. Krauss, MD Speaker Support

Medtronic, St Jude, Boston Scientific Honoraria

Kishore R. Kumar, MBBS PhD No relevant financial interests to disclose for this Speaker FRACP course

Merz Consultant Julie A. Kurek, MD Reviewer Teva- Azilect Honoraria No relevant financial interests to disclose for this Matthew J. LaVoie, PhD Speaker course

Consultant, Advisory Board: Roche Blair R. Leavitt, MDCM, FRCPC Speaker Pharmaceuticals, Ionis Pharmaceuticals, Raptor Consultant Pharmaceuticals, Teva Pharmaceuticals Grant/Research Support No relevant financial interests to disclose for this Jong-Min Lee Speaker course Seung-Jae Lee Speaker Abl Bio, Pangyo, Korea Consultant

Britannia Pharmaceuticals (Genus), BIAL Portela Consultant

Andrew J. Lees, MD, FRCP, FMedSci Chair, Speaker Novartis, Teva, Boehringer Ingelheim, GSK, Ipsen, Lundbeck, Allergan, Orion, BIAL, Roche, Honoraria Britannia, UCB, Nordiclnfu Care,

Hexal Consultant Johannes Levin, MD Speaker General Electric, Bayer Vital Honoraria Willi Gross Stiftung, Aesku No relevant financial interests to disclose for this Christina M. Lill Speaker course.

Katja Lohmann, PhD Chair, Speaker No relevant financial interests to disclose

Ian R. Mackenzie, MD Chair, Speaker No relevant financial interests to disclose

No relevant financial interests to disclose for this Brian MacVicar, PhD Speaker course Abbvie Consultant

BMBF, Deutsche Parkinsongesellschaft, Grant/Research Janssen, Neuroalliance, Hasomed Walter Maetzler, MD Speaker Support

Parts of a patent on dyskinesia assessment in Parkinson's disease Royalty No relevant financial interests to disclose for this Yael Manor, PhD-CCC, SLP Chair, Speaker course No relevant financial interests to disclose for this Vladana Markovic, MD Speaker course

Pfizer, Acorda Consultant Connie Marras, MD, PhD Speaker EMD Serono, Horizon Pharma Honoraria

Wayne Martin, MD Chair UCB Consultant

Pablo Martinez-Martin, MD, PhD Chair, Speaker AbbVie Consultant Raul Martinez, MD Speaker No relevant financial interests to disclose

No relevant financial interests to disclose for this Christopher Mathias, MD Speaker course

Grant/Research Andrew McKeon Speaker Euroimmun and Medimmune Support Advisory Board for Teva Canada Innovation and Novartis Grant/ResearchConsultant Martin J. McKeown, MD, FRCP© Chair Allergan Support Abbvie Honoraria

Wassilios Meissner, MD, PhD Reviewer Orkyn and TEVA/ Lundbeck Honoraria Wassilios Meissner, MD, PhD Reviewer Orkyn and TEVA/ Lundbeck Honoraria No relevant financial interests to disclose for this Niccolo Emanuele Mencacci, MD Speaker course

Aurelie Meneret, MD, PhD Chair, Speaker No relevant financial interests to disclose

GlaxoSmithKline, Otsuka Pharmaceutical, Takahiro Mezaki, MD, PhD Speaker Philips Respironics Honoraria Edison Pharmaceuticals, Medtronic Inc. Censa Inc. Jonathan W. Mink, MD, PhD Chair, Speaker Consultant Grant/Research Abeona Inc. Support

Shekeeb S. Mohammad, MBBS, MD, No relevant financial interests to disclose for this Speaker FRACP course No relevant financial interests to disclose for this Vincent C.T. Mok, MD Speaker course Abbvie, Apopharma Consultant

Orkyn, Abbvie, Apopharma Caroline Moreau, MD, PhD Speaker Consultant (Spouse)

ARSLA, Apopharma,

Micaela Morelli, PhD Chair, Planner No relevant financial interests to disclose

Medtronic Consultant Elena Moro, MD, PhD Chair,Planner Medtronic Honoraria

Merz Pharmaceuticals Consultant Pharm Allergan, Ipsen, Merz Pharmaceuticals, Grant/Research Alexander Münchau, MD Chair, Speaker Actelion Support Merz Pharmaceuticals; Pharm Allergan, Ipsen, Honoraria Desitin, Actelion, GlaxoSmithKline No relevant financial interests to disclose for this Thomas F. Münte Speaker course No relevant financial interests to disclose for this Richard Myers, PhD Speaker course

No relevant financial interests to disclose for this T. Celeste Napier, PhD Speaker course

Alice M. Nieuwboer, PhD Chair, Planner No relevant financial interests to disclose

No relevant financial interests to disclose for this Christer Nilsson, MD,PhD Speaker course

No relevant financial interests to disclose for this Yoshiko Nomura, MD, PhD Speaker course Advisory Board of GSK (UK), GSK (Spain), José A. Obeso, MD, PhD Chair Lundbeck-Teva and UCB. Consultant

Medtronic, Kyowa Hakko Kirin, AbbVie, and Boehringer Ingelheim. Genko Oyama, MD, PhD Speaker Consultant Genko Oyama, MD, PhD Speaker Medtronic, Boston Scientific, Novartis Pharma, MSD, Nihon Medi Phisics, and, Otsuka Pharmaceutical. Honoraria Oxford Biomedica, Boston Scientific, Medtronic Consultant Oxford biomedica Grant/Research Support Stéphane Palfi, MD, PhD Chair Oxford Biomedica, Medtronic, Boston scientific Honoraria No relevant financial interests to disclose for this Toni Pearson, MBBS Speaker course Anthony G. Phillips, CM, PhD, AGP is listed on a patent for the clinical use of Speaker Royalty FRSC, FCAHS the GluR23Y peptide.

Paola P. Piccini, MD, PhD, FRCP Chair, Speaker No relevant financial interests to disclose

Grant/Research Bernd Pichler, PhD Chair, Speaker EU-Projects MultiSyn, Image Link Support No relevant financial interests to disclose for this Christian Pifl Speaker course Grant/Research , Inc., MedImmune Support Inventor on patents (12/678,350 filed 2010 and Sean J. Pittock Speaker 12/573,942 filed 2008) that relate to functional AQP4/NMO-IgG assays and NMO-IgG as a Intellectual Property cancer marker Rights

AbbVie, Allergan, AstraZeneca, Biotie, Boehringer-Ingelheim, Boston Scientific, GlaxoSmithKline, Ipsen, Lundbeck, Medtronic, Werner Poewe, MD Chair, Speaker Consultant, Honoraria MSD, Merck-Serono, Merz Pharmaceuticals, Neuroderm, Novartis, Orion Pharma, Teva, UCB and Zambon

Athena Diagnostics, Inc. (Speaker's Bureau) Ataxion Therapeutics (Honorarium), Takeda Honoraria Pharmaceuticals (Honorarium)

Biomarkers and Treatments for Human Mental and Behavioral States; Intellectual Property Rights (Spouse)

Progenitor Life Sciences (Chief Scientific Officer Ownership - Stock Shareholder, directly purchased)

KromaTID (scientific advisory board - stock options) Stefan M. Pulst, MD Speaker NeuroCircuit Therapeutics (President and CSO - Ownership (Spouse) shareholder) Stefan M. Pulst, MD Speaker

Patents: Nucleic acids encoding ataxin-2 binding proteins; Nucleic acid encoding Schwannomin- binding-proteins and products related thereto; Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide; Methods of detecting spinocerebellar ataxia-2 nucleic acids; Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto; Shwannomin-binding-proteins; Compositions and methods for spinocerebellar ataxia Royalty

Andreas Puschmann, MD, PhD Chair, Speaker No relevant financial interests to disclose

No relevant financial interests to disclose for this Marialuisa Quadri, PhD Speaker course

No relevant financial interests to disclose for this Angelo Quartarone, MD Speaker course

Ipsen Consultant

Alexander Rajput, MD Speaker, Reviewer Teva

Honoraria No relevant financial interests to disclose for this Ali H. Rajput, MD Speaker course

Medtronic Jean Regis Speaker Elekta Consultant

Irena Rektorova, MD, PhD Chair, Planner Abbvie

Honoraria No relevant financial interests to disclose for this Gesine Respondek, MD Speaker course

Teva, Expert Witness Abbvie Consultant Maria C. Rodriguez-Oroz, MD Speaker

Teva, Abbvie Honoraria

Pfizer Neuroscience Global and Regional- Emerging Markets(Pain cluster), Ipsen- International, Abbott Neuroscience-Philippines, Consultant Raymond L. Rosales, MD, PhD Chair, Planner Boehringer Ingelheim Neurology-Philippines and Menarini Neurology-Philippines

Pfizer, Ipsen, Abbott, Boehringer Ingelheim and Honoraria Menarini

Grant/Research John C. Rothwell, MA, PhD Speaker MRC, BBSRC, DMRF Support

No relevant financial interests to disclose for this Brent Ryan Speaker course No relevant financial interests to disclose for this Ryuji Sakakibara Speaker course

St Jude Medical Consultant Bial Pharma UK Ltd, Profile Pharma Ltd (A Michael Samuel, MD Speaker Subsidiary of Zambon SpA) and Medtronic Grant/Research Support

St Jude Medical Honoraria Zambon, Eisai, Sanofi Consultant Anthony H.V. Schapira, DSc, MD Speaker Eisai Grant/Research Support

UCB Honoraria

Filip Scheperjans, MD, PhD Speaker

NeuroInnovation Oy Ownership

GenzymeSanofi, Mass; Shire Inc., Switzerland Consultant GenzymeSanofi Canada Honoraria Licensing by former employer (BWH/Partners Michael G. Schlossmacher, CM MD Chair, Speaker HealthCare) to GenzymeSanofi; Licensing agreement by current employer Intellectual Property (TOH/OHRI) with BioLegend Rights GenzymeSanofi via BWH / Partners HealthCare Inc; Royalty Medtronic, SJM, Boston Scientific, Gruenenthal, Teva Consultant Alfons Schnitzler, MD, PhD Speaker Meda Pharma, Teva, Lundbeck, Boehringer Ingelheim, Medtronic, Novartis Honoraria Sanofi Consultant Matthew Seaman Speaker Grant/Research Medical Research Council Support

Cynapsus Binit B. Shah, MD Speaker Consultant Abbvie No relevant financial interests to disclose for this Aasef G. Shaikh, MD, PhD Speaker course Cynapsus, Lundbeck Consultant Holly A. Shill, MD Speaker Grant/Research Impax, Cynapsus, US World Meds, Axovant Support

Lundbeck A/S, Valby Denmark. Consultant Grant/Research Hartwig R. Siebner, MD DMSci Speaker Biogen-idec, Denmark. Support

Biogen Idec, Denmark A/S, Genzyme, Denmark Honoraria and MerckSerono, Denmark

Bracket Company Harvey S. Singer, MD Chair, Speaker Consultant (review study patient eligibility)

Abbvie, , Egis, Krka, Lundbeck, Matej Skorvanek, MD, PhD Speaker Honoraria Medtronic, Teva and UCB

Allergan Australia Consultant Barry J. Snow, MD Speaker Allergan Australia Consultant Barry J. Snow, MD Speaker Solvay LCT New Zealand Grant/Research Support

Allergan Australia Honoraria Vesna Sossi, PhD Chair, Speaker Cubresa Royalty

Allergan, Genzyme, Eli Lilly, Merz, Osmotica, Mark A. Stacy, MD Chair Pfizer, ProStrakan, SK Life Sciences Consultant No relevant financial interests to disclose for this Antonio P. Strafella, MD, PhD, Reviewer FRCPC course

Acadia, Pharmaceuticals, Adamas Pharmaceuticals, Inc., Ceregene, Inc., Ingenix Glenn T. Stebbins, PhD Speaker Pharmaceutical Services (i3 Research), Neurocrine Biosciences, Inc., Pfizer, Inc. Consultant

Teva, Acorda, Adamas, Impax, US World Meds Matthew B. Stern, MD Chair

Consultant Stock options in Adamas Ownership Agence Nationale pour la Recherche (France) Connaitre les Syndromes cerebelleux (France) Grant/Research APTES Association (France) Support Giovanni B. Stevanin Chair, Speaker Ecole Pratique des Hautes Etudes (France)

Diagnosis of SPG11 and of SPG15. INSERM Royalty Transfert AbbVie, Pfizer, Roche/Genentech Consultant

NTCell Grant/Research A. Jon Stoessl, CM, MD, FRCPC Chair, Planner Support AbbVie, Kyowa Honoraria

No relevant financial interests to disclose for this Jon Stone, FRCP, PhD Speaker course

Ingrid Sturkenboom Speaker Patents industry flow meters Royalty (Spouse) Abbvie, Ipsen, Allergan Consultant Oksana Suchowersky, MD, FRCPC, Speaker Grant/Research FCCMG Brain Canada, Abbvie, Biotie, ApoPharma Support

Carolyn M. Sue, MBBS, PhD, FRACP Chair, Speaker No relevant financial interests to disclose

CBD solutions AB Per Svenningsson, MD PhD Speaker Consultant ERC, Swedish Research Council, CBD solutions Grant/Research AB Support No relevant financial interests to disclose for this Elisabeth Svensson Speaker course

Kan Research Institute INC. Dainippon Sumitomo Pharma Co. Ltd Consultant Ono Pharma Ltd. Takeda Pharmaceutical CO Ltd

Boehringer Ingelheim NOVARTIS DAINIPPON SUMITOMO PHARMA Glaxo Smith Kline Pfizer Co. Ltd. Grant/Research Kyowa Hakko Kirin Co. Ltd. Support Tanabe Mitsubishi Pharma Co. Ltd. Takeda Phamaceutical Co. Ltd. Ryosuke Takahashi, MD, PhD Chair, Speaker Eisai Co. Ltd. Otsuka Pharma. Co. Ltd. Novartis Pharma

FP PHARMACEUTICAL CORP. Boehringer Ingelheim DAINIPPON SUMITOMO PHARMA Kyowa Hakko Kirin Co. Ltd. Tanabe Mitsubishi Pharma Co. Ltd. Honoraria NIHON PHARMACEUTICAL CO. LTD. TEIJIN PHARMA LTD. Glaxo Smith Kline,Eisai Co. Ltd. Otsuka Pharma. Co. Ltd.,Novartis Pharma

Eng-King Tan, MD Chair, Planner No relevant financial interests to disclose

No relevant financial interests to disclose for this Louis CS Tan, FRCP Speaker course No relevant financial interests to disclose for this Daniel Tarsy, MD Speaker course No relevant financial interests to disclose for this Carmela Tartaglia, MD Speaker course Helio A. G. Teive, MD, PhD Chair, Speaker No relevant financial interests to disclose

No relevant financial interests to disclose for this Pichet Termsarasab, MD Speaker course Philip D. Thompson, MB, BS, PhD, Chair, Planner No relevant financial interests to disclose FRACP

Medtronic Inc, Boston Scientific, UCB Consultant Chair, Planner, Grant/Research Lars Timmermann, MD Medtronic, UCB, Bayer, TEVA, Boston Scientific Reviewer Support Teva, UCB, Desitin, Medtronic, Boston Honoraria Scientific,Abbvie, GE Medical, Bayer Vital

Eduardo Tolosa, MD Chair Bial; UCB Consultant; Honoraria

Desitin, Mundipharma, Britannia, UCB, Abbie. Consultant Claudia M. Trenkwalder, MD Chari, Speaker Claudia M. Trenkwalder, MD Chari, Speaker

UCB, Mundipharma, Vifor, Honoraria

No relevant financial interests to disclose for this John Q. Trojanowski, MD, PhD Speaker course Otsuka Pharmatheutical Yoshio Tsuboi, MD Speaker Kyowa Kirin Honoraria Novartis Pharma

Joseph K.C. Tsui, MD Speaker Allergan and Mertz Honoraria

Nihon Kohden, LTD, Takeda Pharmaceutical Company Limited, Nippon Boehringer Ingelheim Grant/Research Co ., Ltd., Mitsubishi Tanabe Pharma Support Corporation

Astellas Pharma Inc., Eisai Co., Ltd., FP Pharmaceutical Corporation, Otsuka Pharmaceutical Co., Ltd., Elsevier Japan K. K., KISSEI PHARMACEUTICAL CO., Ltd., KYORIN Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Chair, Planner, Co., Ltd., GlaxoSmithKline K. K., Sanofi-Aventis Yoshikazu Ugawa, MD, PhD Speaker K.K., DAIICHI SANKYO Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Takeda Honoraria Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, TEIJIN PHARMA LIMITED, Nippon Chemiphar Co., Ltd., NIHON PHARMACEUTICAL Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Bayer Yakuhin, Ltd., and MOCHIDA PHARMACEUTICAL Co., Ltd.

from CHUGAI-IGAKUSHA, Igaku-Shoin Ltd, Royalty Medical View Co. Ltd. No relevant financial interests to disclose for this Enza Maria Valente, MD, PhD Speaker course

No relevant financial interests to disclose for this Martje E. Van Egmond, MD Speaker course

Consultant for MEDISO Andrea Varrone Speaker Consultant Consultant for MNI

Luis Velázquez-Pérez, PhD and DrSc Chair, Speaker No relevant financial interests to disclose

Marie Vidailhet, MD Speaker Merz Consultant

Aleksandar Videnovic, MD Speaker Acorda, Wilson's Therapeutics, Pfizer Consultant

Miquel Vila, MD, PhD Planner No relevant financial interests to disclose

No relevant financial interests to disclose for this Richard Wade-Martins Speaker course

Gregor K. Wenning, MD, PhD Chair, Speaker Astra, Abbvie, Teva Consultant

GlaxoSmithKline, Pfizer, Sanofi, Biogen-IDEC, Andrew West Chair, Speaker Consultant and Acorda Pharmaceuticals No relevant financial interests to disclose for this Jennifer L. Whitwell, PhD Speaker course

No relevant financial interests to disclose for this Yih-Ru Wu, MD Speaker course

Zhi-ying Wu Chair, Speaker No relevant financial interests to disclose